ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,872.16
-2.95%
Dow Jones
42,326.87
-2.58%
US Dollar vs MXN
20.3984
1.09%
Brent Oil
72.735
0.00%
Bitcoin
100,657.54
0.59%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Marinus Pharmaceuticals Inc (MRNS) Cotización

Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc (MRNS)

-3x Mrna
0.2436
-0.0034
(-1.38%)
Al cierre: 18 Diciembre 3:00PM
Delayed by 15 minutes
0.25
0.0064
( 2.63% )
Fuera de horario: 5:41PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
0.25
Postura de Compra
0.2431
Postura de Venta
0.254
Volume Operado de la Acción
3,772,090
0.242 Rango del Día 0.256499
0.2302 Rango de 52 semanas 11.26
Capitalización de Mercado [m]
13.796M
Precio Anterior
0.247
Precio de Apertura
0.25
Hora
4
@
0.2435
Última hora de negociación
17:24:34
Volumen financiero
US$ 936,131
Precio Promedio Ponderado
0.248173
Volumen promedio (3 m)
2,700,312
Acciones en circulación
55,185,622
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.10
Beneficio por acción (BPA)
-2.56
turnover
30.99M
Beneficio neto
-141.41M

Acerca de Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychi... Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.marinuspharma.com
Sede
Wilmington, Delaware, USA
Fundado
-
Marinus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRNS. The last closing price for Marinus Pharmaceuticals was US$0.25. Over the last year, Marinus Pharmaceuticals shares have traded in a share price range of US$ 0.2302 to US$ 11.26.

Marinus Pharmaceuticals currently has 55,185,622 shares in issue. The market capitalisation of Marinus Pharmaceuticals is US$13.63 million. Marinus Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.10.

MRNS Últimas noticias

Más noticias

Form 8-K - Current report

10 Diciembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

10 Diciembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

15 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

14 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Noviembre 2024
Edgar (US Regulatory)

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

ZTALMY® (ganaxolone) Q3 2024 net product revenue of $8.5 million representing growth of 56% versus Q3 2023 Narrowing full year 2024 ZTALMY net product revenue guidance to $33 to $34 million...

12 Noviembre 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.025-9.090909090910.2750.290.230210211030.25870515CS
4-0.06-19.35483870970.310.340.23028627010.29478512CS
12-1.65-86.84210526321.91.960.230227003120.44564061CS
26-1.24-83.22147651011.491.970.230215949830.63799264CS
52-8.25-97.05882352948.511.260.230214567791.77991215CS
156-10.18-97.603068072910.4313.150.23028054514.04359076CS
260-1.35-84.3751.620.040.230210744674.19923433CS

MRNS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Marinus Pharmaceuticals?
El precio actual de las acciones de Marinus Pharmaceuticals es US$ 0.25
¿Cuántas acciones de Marinus Pharmaceuticals están en circulación?
Marinus Pharmaceuticals tiene 55,185,622 acciones en circulación
¿Cuál es la capitalización de mercado de Marinus Pharmaceuticals?
La capitalización de mercado de Marinus Pharmaceuticals es USD 13.63M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Marinus Pharmaceuticals?
Marinus Pharmaceuticals ha negociado en un rango de US$ 0.2302 a US$ 11.26 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Marinus Pharmaceuticals?
El ratio precio/beneficio de Marinus Pharmaceuticals es -0.1
¿Cuál es el ratio de efectivo a ventas de Marinus Pharmaceuticals?
El ratio de efectivo a ventas de Marinus Pharmaceuticals es 0.45
¿Cuál es la moneda de reporte de Marinus Pharmaceuticals?
Marinus Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Marinus Pharmaceuticals?
El último ingresos anual de Marinus Pharmaceuticals es USD 30.99M
¿Cuál es el último beneficio anual de Marinus Pharmaceuticals?
El último beneficio anual de Marinus Pharmaceuticals es USD -141.41M
¿Cuál es la dirección registrada de Marinus Pharmaceuticals?
La dirección registrada de Marinus Pharmaceuticals es 3411 SILVERSIDE ROAD TATNALL BUILDING, #104, WILMINGTON, DELAWARE, 19810
¿Cuál es la dirección del sitio web de Marinus Pharmaceuticals?
La dirección del sitio web de Marinus Pharmaceuticals es www.marinuspharma.com
¿En qué sector industrial opera Marinus Pharmaceuticals?
Marinus Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CURRCurrenc Group Inc
US$ 8.50
(325.00%)
2.89M
APCXAppTech Payments Corporation
US$ 0.6831
(79.29%)
2.19M
FTELFitell Corporation
US$ 9.80
(40.00%)
317.91k
DALNDallasNews Corporation
US$ 6.65
(36.55%)
19.63k
ELABElevai Labs Inc
US$ 2.8699
(33.48%)
1.12M
LITMSnow Lake Resources Ltd
US$ 0.5099
(-37.78%)
10.73M
NUKKNukkleus Inc
US$ 34.20
(-32.66%)
3.65M
MUUDirexion Daily MU Bull 2X Shares
US$ 17.00
(-30.73%)
637.6k
MULLGranite Shares 2x Long MU Daily ETF
US$ 15.30
(-30.04%)
45.49k
AEMDAethlon Medical Inc
US$ 0.5245
(-20.60%)
6.6M
LCIDLucid Group Inc
US$ 2.50
(-1.19%)
37.13M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3651
(0.08%)
15.95M
NVDANVIDIA Corporation
US$ 130.23
(1.02%)
12.59M
MUMicron Technology Inc
US$ 88.01
(-15.29%)
11.73M
LITMSnow Lake Resources Ltd
US$ 0.5099
(-37.78%)
10.73M

MRNS Discussion

Ver más
NASDAQ2020 NASDAQ2020 3 semanas hace
That it is !!!!
👍️0
glenn1919 glenn1919 4 meses hace
MNRS................................https://stockcharts.com/h-sc/ui?s=MNRS&p=W&b=5&g=0&id=p86431144783
👍️0
Money hunt Money hunt 8 meses hace
1.27 Wall gong to get busted down Watch out shorties,
👍️0
Money hunt Money hunt 8 meses hace
MRNS Has got bulls with balls dude
👍️0
Money hunt Money hunt 8 meses hace
Watch out shorties We the Next PALI So you can all burn in hell where you belong
👍️0
ErnieBilco ErnieBilco 8 meses hace
MRSN under $2
👍️0
Awl416 Awl416 8 meses hace
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
👍️0
Monksdream Monksdream 9 meses hace
MRNS under $10
👍️0
oldstocks oldstocks 10 meses hace
Drug Companies making Epilepsy medication
MRNS $10.08
CERE $43.16
STOK $4.98
UCBJF $102.00
SNY $45.63
PFE $27.00
OTSUK $18.36
RespireRx Pharmaceuticals Ticker: RSPI
Is working on Revolutionary New Hope:
KRM-II-81 Drug-Resistant Epilepsy Patients

Don't take my word for it, look at the links that talk about it.

Link found on National Library of Medicine
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders

https://pubmed.ncbi.nlm.nih.gov/35041859/

https://www.neurexplain.com/2024/01/17/revolutionary-krm-ii-81-a-new-hope-for-drug-resistant-epilepsy-patients/

National Institutes of Health
A clinical case of a 19-year-old male patient with pharmacoresistant seizures occurring following parieto-occipital tumor-resection at age 6 ...
KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784158/
👍️0
matt51 matt51 2 años hace
Has Marinus enrolled the eighty-second patient for the phase 3 RSE trial?
👍️0
Cosa Cosa 2 años hace
Did you add more here? This recovered well from the bottom. I was putting all into ARDX and AUPH, didn't add any here.
👍️0
Cosa Cosa 2 años hace
Thanks, I will look.
👍️0
Ganz Ganz 2 años hace
Ha, our time is coming for MRNS Cosa, also check out MIRM
👍️0
Cosa Cosa 3 años hace
Good thing that's all you had lol! This is definitely not volatile enough to trade. And a good investment?...Time will tell.
👍️0
missile_systems missile_systems 3 años hace
Yeah Buddy…. Hoping for good news.
Just stumbled upon this on Friday afternoon.
Only had enough powder to grab a hundred shares.
Please don’t laugh too hard….lol.

Anyway, it’s weird that there haven’t been any posts on this board since before last Christmas!

Peace
mis
👍️0
Cosa Cosa 3 años hace
let's see what happens Monday...
👍️0
Cosa Cosa 3 años hace
Everything I have is Red, not a single green. lol!
👍️0
flsh56 flsh56 3 años hace
... don't look now, it's been six months since this happened, but mrns just decently broke through their 50dma
👍️0
Ganz Ganz 3 años hace
Cosa, you there ?
👍️0
Ganz Ganz 4 años hace
Cosa, good to see you on this board, MRNS - like AUPH - is primed to pop.
👍️0
whytestocks whytestocks 4 años hace
JUST IN: $MRNS 3 Biotech Stocks That Surged Last Week

Dozens of healthcare stocks grew by double-digit percentages last week, and shares of these three drugmakers rose further than nearly all of their peers. Clinical trial results, coronavirus vaccine progress, and a buyout were the major factors that turned these biotech stocks into big gainers la...

Read the whole news MRNS - 3 Biotech Stocks That Surged Last Week
👍️0
ClayTrader ClayTrader 4 años hace
* * $MRNS Video Chart 09-15-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Cosa Cosa 4 años hace
Woohoo! Huge upswing
👍️0
whytestocks whytestocks 4 años hace
NEWS: $MRNS Top Penny Stocks To Buy, Sell Or Hold? Analysts Weigh In On These 4

4 Penny Stocks To Buy Right Now According To Analysts Whether you buy penny stocks because of analysts or simply use ratings in your overall strategy, it helps to get a full lay of the land. What I mean by this is that most retail traders will look at a few facets of certain companies. They...

Find out more MRNS - Top Penny Stocks To Buy, Sell Or Hold? Analysts Weigh In On These 4
👍️0
whytestocks whytestocks 4 años hace
Breaking News: $MRNS Nasdaq Rises Despite Nikola Hit; Marinus Soars

Many investors have been worried about the Nasdaq Composite (NASDAQINDEX: ^IXIC) lately. The index has taken a leadership role during 2020's huge rebound from the coronavirus bear market, but its steep decline in early September made some believe that the best of times for the Nasdaq were no...

Got this from MRNS - Nasdaq Rises Despite Nikola Hit; Marinus Soars
👍️0
UFO UFO 4 años hace
Just announced phase #3 results rocked. Stock is on the way to $10+.

UFO
👍️0
MKthe great MKthe great 4 años hace
??????
👍️0
UFO UFO 4 años hace
Go Marinus!

UFO
👍️0
whytestocks whytestocks 4 años hace
News: $MRNS Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

Clinical trials remain on track, with Refractory Status Epilepticus (SE) trial expected to begin enrollment shortly CDKL5 deficiency disorder (CDD) pivotal topline results on track for Q3; Conference call to be scheduled to discuss CDD data release and business update Organiz...

Find out more MRNS - Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
👍️0
UFO UFO 5 años hace
On the move!

UFO
👍️0
ClayTrader ClayTrader 5 años hace
* * $MRNS Video Chart 05-29-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
UFO UFO 5 años hace
Go Marinus!

UFO
👍️0
agribusiness72 agribusiness72 5 años hace
minor pump from yahoo finance. will see how low it drops before buying in.
👍️0
UFO UFO 5 años hace
Looks like a move is on.

UFO
👍️0
ClayTrader ClayTrader 5 años hace
* * $MRNS Video Chart 03-16-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 años hace
* * $MRNS Video Chart 02-20-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 años hace
* * $MRNS Video Chart 02-18-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
nuclear profitz nuclear profitz 5 años hace
breaking out.
👍️0
Cosa Cosa 5 años hace
Good points. I'm sure they will find something it works on. The science behind it is still unknown. The good thing about ganaxolone is it has very little side effects. So if one of the phases does well it is a gold mine! I traded on the momentum and will get back in a little cheaper and a lot less shares so there is no stress lol.

I like Epidiolex seems to be gaining momentum since it's FDA approval last year. It targets the same symptoms of ganaxolone with very little side effects also.

Good luck to you!
👍️0
UFO UFO 5 años hace
All I've seen them have an issue with is one trial. Now they have a treasure chest full of money and some aggressive money manager backing. IMHO, this would be the WORST time to bail out on the company. Did you read the corporate outlook that was released today? They have about 4 trials in progress and the ability to fund them all. You think ganaxolone is going to fail on all of them? I like the odds here. At the least I think we'll see a rally into the Phase 3 results that we'll see later this year. Go Marinus!

UFO
👍️0
Cosa Cosa 5 años hace
The more I research this stock the more I do not like. Ganaxolone doesnt look like it is doing well in clinical trials.
👍️0
ClayTrader ClayTrader 5 años hace
* * $MRNS Video Chart 12-24-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
Cosa Cosa 5 años hace
Could see that big move up sometime next month

https://www.nasdaq.com/articles/implied-volatility-surging-for-marinus-pharmaceuticals-mrns-stock-options-2019-12-23
👍️0
UFO UFO 5 años hace
Agreed. I've never seen a stock rally like this as a "major" financing is going on! Somebody knows something...just saying...

UFO
👍️0
Cosa Cosa 5 años hace
Possible 10 bagger with a short squeeze.
👍️0
UFO UFO 5 años hace
Go Marinus!

UFO
👍️0
ClayTrader ClayTrader 5 años hace
* * $MRNS Video Chart 12-20-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
UFO UFO 5 años hace
If they get GREAT results from their phase 3, this is a $40 - $50 stock!

UFO
👍️0
Cosa Cosa 5 años hace
If they pass a phase 3 this is going to $10 - $16
👍️0
Cosa Cosa 5 años hace
I'm late to the party. Just got in, more room to grow
👍️0

Su Consulta Reciente

NASDAQ
MRNS
Marinus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados